erad picture

INNOVATIVE SCIENCE

An Orphan Drug Company focusing on the treatment of Gaucher Disease and Cystic Fibrosis by delivering protein therapeutics to all cells in the body including the central nervous system.

OUR SCIENCE

OUR SYNOPSIS

ERAD Therapeutics Inc.

erad picture subpage

INNOVATIVE SCIENCE

Delivering Protein Therapeutics to the CNS for Gaucher Disease

GAUCHER DISEASE

Gaucher Disease is the most common Lysosomal Storage Disease, yet it is still considered an Orphan Disease. Currently affecting over 8,000 American’s, it is a genetic disorder resulting in an enzyme deficiency. Type 1 disease usually results in an enlarged liver, enlarged spleen, anemia and bone disease. Without therapy this significantly impacts both the quality and duration of life. Type 3 disease impacts all of the above as well as causing progressive and ultimately fatal neurological deterioration.

LEARN MORE

CYSTIC FIBROSIS

Cystic Fibrosis is the most common Orphan Disease affecting over 33,000 people in North America. This Orphan Disease affects the respiratory and digestive tracts causing thickening of the mucus in the lungs and digestive fluids causing difficulty breathing, frequent lung infections and significant digestive disorders impact quality and duration of life.

LEARN MORE